| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/09/2007 | US7161061 Encoded by nucleic acid molecule of given sequence; use in producing transgenic plants with increased levels of tocopherol |
| 01/09/2007 | US7161058 Injecting potential tumor cells into a transgenic mouse with a nucleic acid genome encoding the extracellular domain of humanized CTLA4 receptor; administering a candidate drug to the mouse; and monitoring tumor growth |
| 01/09/2007 | US7161057 Transgenic animal; urokinase plasminogen activator; viricides; detecting liver toxicity |
| 01/09/2007 | US7160995 DNA encoding anti-TNF antibodies and peptides |
| 01/09/2007 | US7160994 Osteoclast-specific genes and proteins and uses thereof |
| 01/09/2007 | US7160993 Nucleic acids encoding PRO4400 polypeptides |
| 01/09/2007 | US7160991 Vascular endothelial growth factor polypeptides |
| 01/09/2007 | US7160990 Immunoglobulin for use in detection and prevention staphylococcus infections |
| 01/09/2007 | US7160986 BCL-xγ, a novel BCL-x isoform, and uses related thereto |
| 01/09/2007 | US7160985 For therapy of diabetes |
| 01/09/2007 | US7160982 Peptide substrate identified by type BoNT/B botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 01/09/2007 | US7160981 Peptide antagonists of DP transcription factors |
| 01/09/2007 | US7160924 polyacetal-protein conjugates which demonstrate advantages in bioavailability and biocompatibility compared to unconjugated proteins, without any undesirable side effects e.g., kidney vacuole formation |
| 01/09/2007 | US7160899 Use of at least one compound with neurotrophic activity and at least one adenosine A2A receptor antagonist for the manufacture of a medicament for the treatment, prevention or alleviation of Parkinson's disease in a subject |
| 01/09/2007 | US7160868 Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors |
| 01/09/2007 | US7160864 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells |
| 01/09/2007 | US7160863 Fusion protein contains amino acid sequence with 9 to 13 residues of arginine; antagonist of Nuclear Factor Activated T cell (NFAT); short effectiveness and no side effects or antigenicity; signal sequence, immunosuppressants, biodrugs |
| 01/09/2007 | US7160862 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash or gum patch |
| 01/09/2007 | US7160861 Methods of inducing IL-10 production |
| 01/09/2007 | US7160857 Methods for increasing schwann cell survival |
| 01/09/2007 | US7160856 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents |
| 01/09/2007 | US7160855 Enhancement of iron chelation therapy |
| 01/09/2007 | US7160727 Transducing a neuron with a transgene from the pseudotyped retrovirus virion; gene therapy for neurodegenerative diseases |
| 01/09/2007 | US7160726 Compositions comprising conditioned cell culture media and uses thereof |
| 01/09/2007 | US7160725 Hedgehog signaling promotes the formation of three dimensional cartilage matrices |
| 01/09/2007 | US7160722 Master bone formation transcription factor: compositions and methods of use |
| 01/09/2007 | US7160720 Nucleotide sequences coding enzymetic polypeptide for use in the treatment of cardiovascular disorders |
| 01/09/2007 | US7160705 Arginine repressor deficient strain of coryneform bacterium and method for producing L-arginine |
| 01/09/2007 | US7160701 Genes for detecting bacteria and a method for detecting bacteria by using the genes |
| 01/09/2007 | US7160699 Biosynthesis of botulinium toxins by anaerobic fermentation of Clostridium botulin toxins |
| 01/09/2007 | US7160698 Transformed plant or fish cells with the isolated polynucleotide; wider array of colors and biochemical features compared to existing wild-type green fluorescent protein |
| 01/09/2007 | US7160697 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer |
| 01/09/2007 | US7160696 Bovine lymphocyte-derived antibacterial protein |
| 01/09/2007 | US7160695 For therapy of inflammatory disease; disorder associated with inappropriate apoptosis |
| 01/09/2007 | US7160694 Nucleic acids encoding TANGO405 and functional fragments and uses thereof |
| 01/09/2007 | US7160693 Human hydrolase family members and uses thereof |
| 01/09/2007 | US7160691 Protein fragment complementation assays for the detection of biological or drug interactions |
| 01/09/2007 | US7160688 Screening methods using novel BT toxin receptors from lepidopteran insects |
| 01/09/2007 | US7160685 Peptides having SEQ ID NO: 2 with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/09/2007 | US7160549 including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter |
| 01/09/2007 | US7160548 Genetic engineering; screening for tuberculosis |
| 01/09/2007 | US7160546 Immunizing an animal with a polypeptide; recovering an antibody which binds polypeptide |
| 01/09/2007 | US7160545 Useful for treatment and prevention of prostate cancer; is recognized by cytotoxic T lymphocytes |
| 01/09/2007 | US7160543 Tumor necrosis factor nucleic acid; antiinflammatory agents, autoimmune disease, viricides, parasiticides, central nervous system disorders; anti-TNF peptides inhibit and/or neutralize epitopes of human tumor necrosis factor-alpha |
| 01/09/2007 | US7160542 Method of treating psoriasis using human anti-TNF antibodies and fragments |
| 01/09/2007 | US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/09/2007 | US7160539 Altering T cell mediated immunity comprising altering local extracellular concentrations of tryptophan and tryptophan metabolites |
| 01/09/2007 | US7160536 Radiolabelled metal transport proteins as imaging agents |
| 01/09/2007 | CA2406820C Improvement of flower morphology of plants by targeting mads-box gene |
| 01/09/2007 | CA2365697C Improved methods for recombinant peptide production |
| 01/09/2007 | CA2333196C Bioriented polyethylene film with a high water vapor transmission rate |
| 01/09/2007 | CA2327107C Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same |
| 01/09/2007 | CA2309790C Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 01/09/2007 | CA2269097C Synthesis and purification of hepatitis c virus-like particles |
| 01/09/2007 | CA2263129C Mammalian cell surface antigens; related reagents |
| 01/09/2007 | CA2236751C Method for producing a correctly folded, biological active recombinant protein |
| 01/09/2007 | CA2234557C Method for the production of hybrid plants |
| 01/09/2007 | CA2232325C Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 01/09/2007 | CA2168268C Aids and sle prophylactics |
| 01/09/2007 | CA2163233C Immortalized human cell lines containing exogenous cytochrome p450 genes |
| 01/09/2007 | CA2150667C A gene which determines cytoplasmic sterility and a method of producing hybrid plants using said gene |
| 01/09/2007 | CA2141454C Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 01/09/2007 | CA2095153C Genetic modification of endothelial cells |
| 01/09/2007 | CA2094245C Streptolysin o derivatives |
| 01/04/2007 | WO2007002633A2 Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain (plad) of tumor necrosis factor receptors |
| 01/04/2007 | WO2007002574A2 Cspcna isoform modifications and uses thereof |
| 01/04/2007 | WO2007002482A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 01/04/2007 | WO2007002419A1 Conformer-specific antibodies and method of use, thereof |
| 01/04/2007 | WO2007002069A2 Serum biomarkers for breast cancer |
| 01/04/2007 | WO2007001737A2 Methods and compositions for detecting herpes simplex virus type 2 |
| 01/04/2007 | WO2007001677A2 Compositions and methods for immunomodulation in an organism |
| 01/04/2007 | WO2007001273A1 A device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 01/04/2007 | WO2007001094A1 Artificial lung surfactant composition |
| 01/04/2007 | WO2007000935A1 Peptide derived from prostate-related protein as cancer vaccine candidate for prostate cancer patient who is positive for hla-a3 super-type allele molecule |
| 01/04/2007 | WO2007000880A1 RICE BLAST DISEASE GENE Pi21, RESISTANCE GENE pi21 AND UTILIZATION THEREOF |
| 01/04/2007 | WO2007000770A2 Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes |
| 01/04/2007 | WO2007000769A2 RECOMBINANT INTERFERON α2 (IFNα2) MUTANTS |
| 01/04/2007 | WO2007000768A2 Gliomedin, fragments thereof and methods of using same |
| 01/04/2007 | WO2007000675A2 Recombinant trimeric 4-1bbl |
| 01/04/2007 | WO2007000672A2 Peptidic antagonists of class iii semaphorins/neuropilins complexes |
| 01/04/2007 | WO2007000584A1 Treatment of fungal and/or protist infections |
| 01/04/2007 | WO2007000320A2 Method for diagnosing rheumatic diseases |
| 01/04/2007 | WO2007000118A1 Exendin 4 polypeptide fragments and use thereof |
| 01/04/2007 | WO2007000077A1 A bentazon and sulfonylurea herbicide-resistant gene cyp81a6 of rice |
| 01/04/2007 | WO2006124152A3 Method for using a static electric field to induce crystallization and to control crystal form |
| 01/04/2007 | WO2006106521A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 01/04/2007 | WO2006076596A3 Generation of plants with altered oil content |
| 01/04/2007 | WO2006074891A3 Proteins containing regulatory t-cells for the therapy and diagnosis of illnesses |
| 01/04/2007 | WO2006073493A3 Vaccine conjugates comprising a monoclonal antibody binding to human dentritic cells and beta human chronic gonadotropin |
| 01/04/2007 | WO2006071250A3 Soluble fragments of the sars-cov spike glycoprotein |
| 01/04/2007 | WO2006068480A3 Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use |
| 01/04/2007 | WO2006044839A3 Increased wax production in plants |
| 01/04/2007 | WO2006037655A3 Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes |
| 01/04/2007 | WO2006017853A3 Mutant interleukin-15-containing compositions and suppression of an immune response |
| 01/04/2007 | WO2006017824A3 Igf-bp3-related methods for inhibiting tumor growth |
| 01/04/2007 | WO2005112994A8 Nodavirus-vlp immunization composition |
| 01/04/2007 | WO2005110039A3 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof |
| 01/04/2007 | WO2005074546A3 Modified human growth hormone polypeptides and their uses |
| 01/04/2007 | WO2005046450A3 Method for diagnosis and treatment of pulmonary disorders |
| 01/04/2007 | WO2005028634A3 Improved mva vaccines |